Similar Search Results

How do drug prices respond to a change from external to internal reference pricing? : evidence from a Danish regulatory reform

Kaiser, Ulrich; Mendez, Susan J. - 2015 - This version: January 5, 2015

We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals using quasi-experimental data for Denmark which switched from external (where reimbursements are based on prices of similar products in foreign countries) to internal reference...

Persistent link: https://www.econbiz.de/10010462523

Corporate integrity culture and compliance : a study of the pharmaceutical industry

Altamuro, Jennifer L. M.; Gray, John V.; Zhang, Haiwen - In: Contemporary accounting research : the journal of the … 39 (2022) 1, pp. 428-458

Persistent link: https://www.econbiz.de/10013165395

Between anxiety and hope? : how actors experience regulatory uncertainty in creative processes in music and pharma

Dobusch, Leonhard; Hondros, Konstantin; Quack, Sigrid; … - In: Organizing creativity in the innovation journey, (pp. 137-160). 2021

Persistent link: https://www.econbiz.de/10012888524

Consequences of disclosing clinical trial results : evidence from the food and drug administration amendments act

Bourveau, Thomas; Capkun, Vedran; Wang, Yin - 2020

We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics,...

Persistent link: https://www.econbiz.de/10012295656

Umbrella branding in pharmaceutical markets

Suppliet, Moritz - 2017

Persistent link: https://www.econbiz.de/10011734578

The economic driven by politics as values : the example of pharmaceuticals in France

Smith, Andy - In: New political economy 22 (2017) 6, pp. 611-627

Persistent link: https://www.econbiz.de/10011742973

Global flows of knowledge : expectations toward transnational regulatory aspects of intellectual property rights in the 20th century chemical industry

Pahlow, Louis; Schneider, Michael C. - In: Management & organizational history : M&OH 14 (2019) 4, pp. 350-365

Persistent link: https://www.econbiz.de/10012177274

Regulating drugs : resolving conflicts with the UN drug control treaty system

Walsh, John; Jelsma, Martin - In: Journal of illicit economies and development : JIED 1 (2019) 3, pp. 266-271

treaties is untenable and risks undermining basic principles of international law. States enacting cannabis regulation must … drug control conventions so as to accommodate cannabis regulation is not feasible for the foreseeable future, and the … regulation with arguments of citizens’ health and safety, and justifying it with an appeal to human rights obligations; (4 …

Persistent link: https://www.econbiz.de/10012261153

Achieving dynamic efficiency in pharmaceutical innovation : identifying the optimal share of value and payments required

Woods, Beth; Lomas, James; Sculpher, Mark; Weatherly, Helen - In: Health economics 33 (2024) 4, pp. 804-819

Persistent link: https://www.econbiz.de/10014514558

Chapter Twelve. Markets for Pharmaceutical Products

Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011

also characterized by extensive regulation of almost every activity, from product development through manufacturing and …

Persistent link: https://www.econbiz.de/10014025576